Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Karlqvist, Sara
6  Ergebnisse:
Personensuche X
?
1

Comparative risk of serious infection with vedolizumab vs a..:

Karlqvist, Sara ; Sachs, Michael C ; Eriksson, Carl...
American Journal of Gastroenterology.  , 2024
Link: https://doi.org/10.14309..
 
?
2

Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents..:

Eriksson, Carl ; Söderling, Jonas ; Karlqvist, Sara...
Digestive Diseases and Sciences.  68 (2023)  7 - p. 3119-3128 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Long-term outcomes of vedolizumab in inflammatory bowel dis..:

Visuri, Isabella ; Eriksson, Carl ; Karlqvist, Sara...
Therapeutic Advances in Gastroenterology.  16 (2023)  - p. 175628482311749 , 2023
Link: https://doi.org/10.1177/..
 
?
4

Long-term outcomes of vedolizumab in inflammatory bowel dis..:

Visuri, Isabella ; Eriksson, Carl ; Karlqvist, Sara...
Therapeutic Advances in Gastroenterology, 1756-283X, 2023, 16,.  , 2023
Link: http://urn.kb.se/resolve..
 
?
5

Ustekinumab Versus Anti-tumour Necrosis Factor Alpha Agents..:

Eriksson, Carl ; Söderling, Jonas ; Karlqvist, Sara...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293383/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
6

Long-term outcomes of vedolizumab in inflammatory bowel dis..:

Isabella Visuri ; Carl Eriksson ; Sara Karlqvist...
https://doi.org/10.1177/17562848231174953.  , 2023
Link: https://doi.org/10.1177/..
 
1-6